The «year of women» is off to a bad start
According to the Global Wellness Institute, 2026 is the year of women. Indeed, it seems women’s health is talked about more than ever, yet, in practice, many women still report the same patterns of dismissal, delayed diagnosis and unmet needs.
They leave appointments with fewer answers than what they could find in conversations with friends or online communities. The problem is no longer silence, it is non-consequential listening. Rhetorically embracing women’s health while the actual mechanisms of inclusion remain weak or performative is not satisfying.
At the same time, a real shift is underway. Investment and innovation in women’s health are growing, from menopause and fertility platforms to diagnostics, wearables and new models of care. Large institutions also pledge funding and attention. Still, progress remains uneven because the pipeline from experience to evidence to guidelines to concrete patient care is slow, selective and shaped by incentives that do not always align with patients’ needs.
The issue isn’t whether women are «heard», but whether their reports change decisions inside the systems that allocate time, credibility and care. Therefore, how can we ensure that critical feedback leads to learning rather than defensiveness and that reports from women and health professionals are treated as actionable clinical signals rather than dismissed as anecdotal?
Several barriers keep women’s health stuck, maintaining data gaps:
Women have been underrepresented in clinical trials, so diagnostic criteria and treatment thresholds often reflect male bodies, with women’s symptoms labeled as «atypical».
Education lags too: many clinicians receive limited education in women’s health and feel ill equipped to deal with sex and genders differences.
Even when evidence does exist, it can take years to reach everyday practice, sometimes for good reasons (safety and rigor), but sometimes decisions about what gets prioritized and resourced can be uneven and not always aligned with patient benefit (for example, persistent delays in endometriosis diagnosis and wide variation in access to menopause hormone-therapy options). Often, medical guidelines update slowly and busy clinicians may therefore rely on outdated protocols. Indeed, after medical school, doctors must navigate an overwhelming and fragmented flow of information from conferences, journals and pharmaceutical representatives, while running time-intensive practices that leave little room for independent research. Expecting clinicians to stay fully current under these conditions is unrealistic and women’s health pays the price.
Finally, funding and reward structures influence which questions get studied and what ultimately accumulates into the evidence base. Academic careers often depend on steady publication and grant success, which can nudge research toward projects that are faster to execute, easier to publish or more likely to attract attention than women’s health topics.
When mainstream care cannot offer clear answers, other actors step in, sometimes responsibly, sometimes not. Skepticism toward influencer-driven «hormone balancing» and «testing packages» is warranted, but dismissing every outside initiative as «do-it-yourself» misses the deeper question: What do we do when evidence-based research does not provide answers to very real problematics? Evidence-based medicine matters, but it is not the only lens women’s health should be looked at and it isn’t a substitute for clinical judgment, humility and serious attention to lived experience.
I have seen how professional hierarchies can shut down legitimate questions: challenging established practices or raising emerging evidence can trigger suspicion, especially when the question comes from a non-physician clinician. That dynamic reinforces the stagnation we say we want to escape.
So, is there space, beyond large well-funded projects, for everyday critical voices to contribute insights that highlight gaps especially around prevention and long-term follow-up?
I argue that progress requires widening the table of women’s health professionals and strengthening the tools between seats: especially clearer, co-created resources that improve communication between patients, clinicians and other health professionals, as well as better education on female physiology and hormonal transitions in a woman’s life. Above all, we must normalize humility in medicine, not only the willingness to say «we don’t know», but the willingness to keep looking together for answers. Women’s health «on the field» will not advance through silos or gatekeeping, but through collaboration, curiosity and mutual respect.
